Investor Jorey Chernett reports 6.3% IO Biotech (IOBT) stake in 13G/A

Rhea-AI Filing Summary

IO Biotech, Inc. investor Jorey Chernett filed Amendment No. 1 to a Schedule 13G reporting beneficial ownership of 4,543,532 shares of IO Biotech common stock, representing 6.3% of the class as of December 31, 2025.

Chernett reports sole voting and dispositive power over all 4,543,532 shares, with no shared voting or investment authority and no membership in a filing group. The certification states that the shares were not acquired to change or influence control of IO Biotech.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

(Amendment No. 1)

IO Biotech, Inc.

(Name of Issuer)

Common

(Title of Class of Securities)

449778109

(CUSIP Number)

12/31/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 449778109

1

Names of Reporting Persons

Chernett Jorey

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

UNITED STATES

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 4,543,532.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 4,543,532.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

4,543,532.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.3 %

12

Type of Reporting Person (See Instructions)

IN

SCHEDULE 13G

Item 1.
(a)	Name of issuer: IO Biotech, Inc.
(b)	Address of issuer's principal executive offices: OLE MAALOES VEH 3, COPENHAGEN, DENMARK, 2200.
Item 2.
(a)	Name of person filing: Jorey Chernett
(b)	Address or principal business office or, if none, residence: 6222 Indianwood Trail, Bloomfield Hills, MI 48301
(c)	Citizenship: US
(d)	Title of class of securities: Common
(e)	CUSIP No.: 449778109
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 4,543,532
(b)	Percent of class: 6.31%
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 4,543,532
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 4,543,532
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
	Not Applicable
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Chernett Jorey

Signature:	/s/Jorey Chernett
Name/Title:	Individual
Date:	02/13/2026

FAQ

What ownership stake in IO Biotech (IOBT) does Jorey Chernett report?

Jorey Chernett reports beneficial ownership of 4,543,532 IO Biotech common shares, representing 6.3% of the class. This level of ownership makes Chernett a significant shareholder under SEC rules requiring Schedule 13G filings.

What type of SEC filing did Jorey Chernett submit for IO Biotech (IOBT)?

Jorey Chernett submitted an Amendment No. 1 to Schedule 13G for IO Biotech, Inc. This filing updates previously reported beneficial ownership information once the investor holds more than 5% of the company’s common stock.

Does Jorey Chernett have sole voting power over IO Biotech (IOBT) shares?

Yes. The filing shows sole voting power over 4,543,532 shares and no shared voting power. Chernett also has sole dispositive power over the same number of shares, meaning individual authority to decide if and when they are sold.

What is the effective date of Jorey Chernett’s reported IO Biotech (IOBT) holdings?

The reported ownership is tied to a Date of Event of December 31, 2025. That date marks when the ownership position met the threshold that required this updated Schedule 13G/A disclosure with the SEC.

Is Jorey Chernett seeking to influence control of IO Biotech (IOBT)?

The certification states the securities were not acquired and are not held for the purpose of changing or influencing control of IO Biotech. The filing characterizes the position as passive under the Schedule 13G framework.

Is Jorey Chernett part of a group holding IO Biotech (IOBT) shares?

No. The ownership section marks group-related items as Not Applicable, and the filing lists only one reporting person, Jorey Chernett, indicating the stake is not reported as part of a coordinated shareholder group.